Healthcare has been one of the hottest investor sectors during the past three years and, as a result, the multiples for many of these stocks are getting up there. That being said, the names on our list today could see pressure on its share price in the coming days.
TSO3 Inc. (TSX: TOS) – $1.99
Biotechnology & Medical Research
TSO3 Inc. encompasses the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes used in hospitals.
- Market Cap: $166,690,237
- Operating Profit (LTM): -$6,984,760
- EV/Revenue (LTM): 99.1x
- P/B (LFQ): 10.1x
Related: 6 Biotech/Pharma Stocks with ‘Unhealthy’ Valuations >>
ProMetic Life Sciences Inc. (TSX: PLI) – $3.02
Pharmaceuticals
ProMetic Life Sciences Inc. (ProMetic) is a Canada-based biopharmaceutical company that offers solutions in bioseparations, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens. The Company operates through two segments: Therapeutics and Protein Technology.
- Market Cap: $1,715,905,181
- Operating Profit (LTM): -$47,453,000
- EV/Revenue (LTM): 82.2x
- P/B (LFQ): 13.9x
Find
out what industry experts Jason Donville and Bruce Campbell are saying about the Canadian healthcare space, including their
top stocks picks here and
here.
Neovasc Inc. (TSX: NVC) – $5.46
Advanced Medical Equipment & Technology
Neovasc Inc. (Neovasc) is a Canada-based specialty medical device company engaged in developing, manufacturing and marketing products for the cardiovascular market. The Company’s products include Tiara, an early-stage development product used for the transcatheter treatment of mitral valve disease; Reducer for the treatment of refractory angina, and Peripatch, a biological tissue product that is manufactured from pericardium.
- Market Cap: $383,136,635
- Operating Profit (LTM): -$33,857,450
- EV/Revenue (LTM): 22.9x
- P/B (LFQ): 4.3x
Looking for more hidden gems? Get your free Ubika Mining 20 Monthly report.
The Ubika Mining 20 (UM20) index slipped 3.4% during the past month yet handily beat the 13.1% slump by the TSX Mining Index, UM20’s closest benchmark. The TSX Venture index, meanwhile, eased 1.3%. Lucara Diamond Corp. (TSX: LUC) was the top-performing component company this month, powering 27% higher after announcing the recovery of the second largest gem-quality diamond ever mined. Get your copy of the Ubika Mining 20 report here >>
Spectral Medical Inc. (TSX: EDT) – $0.84
Medical Equipment, Supplies & Distribution
Spectral Medical Inc. (Spectral), formerly Spectral Diagnostics Inc., is a therapeutic development company focused on the development and commercialization of a treatment for severe sepsis and septic shock utilizing its Endotoxin Activity Assay (EAA) and the Toraymyxin (PMX) therapeutic. The Company also manufactures and sells certain reagents.
- Market Cap: $156,553,702
- Operating Profit (LTM): -$9,715,000
- EV/Revenue (LTM): 48.2x
- P/B (LFQ): 20.4x
Novadaq Technologies Inc. (TSX: NDQ) – $15.00
Advanced Medical Equipment & Technology
Novadaq Technologies Inc. develops and commercializes medical imaging and therapeutic devices for use in the operating room. The Company’s imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. Novadaq generates revenues from the sale of medical devices and consumables, capital devices or consumable products, the rental of capital devices, royalties, upfront payments received from partners for exclusive sales and marketing rights, and extended warranty services agreements in connection with capital sales.
- Market Cap: $858,997,322
- Operating Profit (LTM): -$49,840,986
- EV/Revenue (LTM): 9.8x
- P/B (LFQ): 4.3x
